CBD has been proven to have anti-seizure properties that can successfully treat children with drug-resistant types of neurological disorders like epilepsy.
In a study published in the New England Journal of Medicine, CBD showed a decrease in the frequency of seizures by 23 percentage points over those taking a placebo.
In fact, in June 2018, the US Food and Drug Administration (FDA) advisors approved the prescription use of Epidiolex, a purified form of CBD oil, for treating two rare and severe forms of epilepsy in patients of the ages of 2 years and older. These two forms of epilepsy – Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) – generally don’t respond to anti-seizure medications.
Epidiolex happens to be the first FDA-approved drug that contains a purified form of a drug derived from marijuana. This drug reduces the seizures and sometimes stops them altogether. Remarkable visual proof of its effects on children suffering from “childhood epilepsy” is available on the internet for people to view.
On June 25, Dr. Scott Gottlieb, on behalf of the FDA, stated: “Today, the FDA approved a purified form of the drug cannabidiol (CBD)…The new product was approved to treat seizures associated with two rare, severe forms of epilepsy in patients two years of age and older.”
Research has also suggested that CBD can help treat complications arising from epilepsy, like neurodegeneration, neuronal injury, and psychiatric diseases.